AXSOME THERAPEUTICS, INC. Cash
AXSOME THERAPEUTICS, INC. (AXSM) had Cash of $86.47 million as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2022-03-01
- 2021-12-31: Cash $86.47M.
- 2021-09-30: Cash $114.62M.
- 2021-06-30: Cash $141.22M.
- 2021-03-31: Cash $164.66M.
| Period end | Cash |
|---|---|
| 2021-12-31 | $86.47M 10-K · filed 2022-03-01 |
| 2021-09-30 | $114.62M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $141.22M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $164.66M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $183.88M 10-K · filed 2022-03-01 |
| 2020-09-30 | $202.36M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $190.68M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $197.31M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $219.97M 10-K · filed 2022-03-01 |
| 2019-09-30 | $43.64M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $53.75M 10-Q · filed 2020-08-10 |
| 2019-03-31 | $42.62M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $13.97M 10-K · filed 2022-03-01 |
| 2018-09-30 | $15.22M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $20.35M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $26.63M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $34.02M 10-K · filed 2021-03-01 |
| 2017-09-30 | $31.67M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $37.99M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $45.02M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $36.62M 10-K · filed 2020-03-12 |
| 2016-09-30 | $33.89M 10-Q · filed 2017-11-08 |
| 2016-06-30 | $38.75M 10-Q · filed 2017-08-09 |
| 2016-03-31 | $44.08M 10-Q · filed 2017-05-09 |
| 2015-12-31 | $48.04M 10-K · filed 2019-03-15 |
| 2015-09-30 | $4.62M 10-Q · filed 2016-11-14 |
| 2015-06-30 | $6.41M 10-Q · filed 2016-08-09 |
| 2015-03-31 | $1.69M 10-Q/A · filed 2016-08-09 |
| 2014-12-31 | $2.62M 10-K · filed 2018-03-07 |
| 2013-12-31 | $2.09M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |